Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT01896050
Eligibility Criteria:
Inclusion Criteria:
* Stage 0-III breast cancer who are scheduled to receive endocrine therapy with tamoxifen or an aromatase inhibitor
* All prior surgery and chemotherapy should be complete
* Age 18 and above and postmenopausal
Exclusion Criteria:
* Major rheumatologic disorders
* Concomitant sex hormone containing drugs or Leutinizing Hormone Releasing Hormone agonist therapy
* For those subjects initiating treatment with an aromatase inhibitor, prior tamoxifen within 4 weeks of enrollment
* For those subjects initiating treatment with tamoxifen, prior aromatase inhibitor within 4 weeks of enrollment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01896050
Study Brief:
Protocol Section:
NCT01896050